- Home
- ALEC vs CD Comparison
ALEC vs CD Comparison
Compare ALEC & CD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | CD |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.8M | 323.4M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ALEC | CD |
|---|---|---|
| Price | $1.83 | $8.65 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.90 | N/A |
| AVG Volume (30 Days) | ★ 4.0M | 279.6K |
| Earning Date | 11-05-2026 | 08-31-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $21,045,000.00 | $1,867,068.00 |
| Revenue This Year | $214.33 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 277.93 |
| 52 Week Low | $1.09 | $2.10 |
| 52 Week High | $2.76 | $14.10 |
Technical Indicators
Market Signals| Indicator | ALEC | CD |
|---|---|---|
| Relative Strength Index (RSI) | 44.29 | 61.04 |
| Support Level | $1.43 | $3.62 |
| Resistance Level | $2.17 | $10.57 |
| Average True Range (ATR) | 0.20 | 1.87 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 22.55 | 45.32 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About CD Chaince Digital Holdings Inc. Ordinary Shares
Chaince Digital Holdings Inc is digital fintech company providing access to the growing AI-powered infrastructure, blockchain, and digital assets. Its three core business lines include: blockchain and digital asset solutions, AI and HPC infrastructure, developing liquid cooling solutions for AI data centers and comprehensive financial services through Chaince Securities,LLC a FINRA-registered broker-dealer, and RIA.